Concepedia

John R. Lever

JR

Statistics

Publications

74

Citations

3.3K

H-Index

29

Active since

1980

Affiliations

Johns Hopkins University(Current)

University of Missouri

Harry S. Truman Memorial Veterans' Hospital

University of North Dakota

National Institute on Drug Abuse

John R. Lever is an author at Johns Hopkins University specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

Publications per year

1980–2019

74

Publications

74

Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity

Nripen Chanda, Vijaya Kattumuri, Ravi Shukla et al. · Proceedings of the National Academy of Sciences · 2010 · 321 citations

Laminin receptor specific therapeutic gold nanoparticles ( <sup>198</sup> AuNP-EGCg) show efficacy in treating prostate cancer

Ravi Shukla, Nripen Chanda, Ajit Zambre et al. · Proceedings of the National Academy of Sciences · 2012 · 264 citations · Full text

Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor–bearing mice

Nripen Chanda, Para Kan, Lisa Watkinson et al. · Nanomedicine Nanotechnology Biology and Medicine · 2009 · 230 citations

, , +11

Quantification of mu and non–mu opiate receptors in temporal lobe epilepsy using positron emission tomography

Helen S. Mayberg, Bernard Sadzot, Carolyn C. Meltzer et al. · Annals of Neurology · 1991 · 170 citations

Phorbol ester induced trafficking‐independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol

James D. Foster, Steven Adkins, John R. Lever et al. · Journal of Neurochemistry · 2008 · 136 citations · Full text

Rows per page

1–5 of 74